指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

低血糖高风险时间:基于共识的住院患者连续葡萄糖监测指标验证

Time at High Risk of Hypoglycemia: Validation of a Consensus-Based Continuous Glucose Monitoring-Metric for Hospitalized Patients.
指南 / 共识 · J Diabetes Sci Technol · 2025-04-11
一句话结论在非ICU住院2型糖尿病接受基础-餐时胰岛素治疗患者中,低血糖高风险时间(THRH)与低血糖强烈相关,目标THRH低于50%与推荐TBR<3.9 mmol/L低于4%一致。

本研究分析DIATEC试验中166例非ICU住院2型糖尿病患者的CGM数据,所有患者接受基础-餐时胰岛素治疗,其中82例接受床旁血糖检测和盲法CGM,84例接受开放CGM。线性回归和负二项回归分析显示,THRH每增加10个百分点,TBR(<3.0 mmol/L)增加0.13个百分点(95%CI=0.06-0.21),TBR(3.0-3.9 mmol/L)增加0.66个百分点(95%CI=0.47-0.86),TBR(<3.9 mmol/L)增加0.74个百分点(95%CI=0.51-0.97),均P<.001。THRH阈值低于50%与TBR<3.9 mmol/L低于4%相关,日间和夜间分析及床旁血糖监测患者中结果相似,低血糖事件亦相似。结论认为THRH与低血糖强烈相关,目标THRH低于50%与推荐TBR目标一致,支持THRH在指导低血糖预防策略中的作用。

要点

  • 在非ICU住院2型糖尿病接受基础-餐时胰岛素治疗患者中,THRH每增加10个百分点,TBR(<3.0 mmol/L)增加0.13个百分点(95%CI=0.06-0.21),TBR(3.0-3.9 mmol/L)增加0.66个百分点(95%CI=0.47-0.86),TBR(<3.9 mmol/L)增加0.74个百分点(95%CI=0.51-0.97),均P<.001。
  • THRH阈值低于50%与TBR<3.9 mmol/L低于4%相关,与推荐目标一致。
  • 日间(07:00-23:00)和夜间(23:01-06:59)分析结果相似,床旁血糖监测患者中结果亦相似。
  • THRH与低血糖事件亦相关。
  • THRH是基于CGM的指标,推荐用于住院患者报告。

适用人群与场景

  • 非ICU住院2型糖尿病患者,来自DIATEC试验,共166例,所有患者接受基础-餐时胰岛素治疗。

诊断标准与关键阈值

  • THRH定义为CGM葡萄糖3.9至5.6 mmol/L的时间百分比。
  • TBR(<3.0 mmol/L)、TBR(3.0-3.9 mmol/L)、TBR(<3.9 mmol/L)为低血糖时间百分比。
  • THRH阈值低于50%与TBR<3.9 mmol/L低于4%相关。

研究设计与关键结果

  • 研究类型为对DIATEC试验数据的分析,样本量166例非ICU住院2型糖尿病患者,其中82例接受床旁血糖检测和盲法CGM,84例接受开放CGM。
  • 在CGM监测患者中,THRH每增加10个百分点,TBR(<3.0 mmol/L)增加0.13个百分点(95%CI=0.06-0.21),TBR(3.0-3.9 mmol/L)增加0.66个百分点(95%CI=0.47-0.86),TBR(<3.9 mmol/L)增加0.74个百分点(95%CI=0.51-0.97),均P<.001。
  • THRH阈值低于50%与TBR<3.9 mmol/L低于4%相关。
  • 日间和夜间分析结果相似,床旁血糖监测患者中结果亦相似,低血糖事件亦相似。

证据类型、等级与局限

  • 证据类型:对DIATEC试验数据的分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在非ICU住院2型糖尿病接受基础-餐时胰岛素治疗患者中,THRH与低血糖强烈相关,目标THRH低于50%与推荐TBR目标一致,支持THRH在指导低血糖预防策略中的作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Time at high risk of hypoglycemia (THRH), 3.9 to 5.6 mmol/L, is a continuous glucose monitoring (CGM)-based metric recommended for reporting in hospitalized patients. This study aims to validate THRH as a predictor of hypoglycemia.

METHODS: The CGM data from 166 non-intensive care unit (non-ICU) inpatients with type 2 diabetes from the DIATEC trial were analyzed. All participants received basal-bolus insulin therapy. Of these, 82 were monitored with point-of-care glucose testing and blinded CGM, while 84 had open CGM. Linear and negative binomial regression analyses assessed the relationship between THRH and time below range (TBR) (<3.0 mmol/L, 3.0-3.9 mmol/L, and <3.9 mmol/L) and hypoglycemic events. Analyses were conducted for day (07:00-23:00), night (23:01-06:59), and 24-hour periods.

RESULTS: For CGM-monitored patients, every 10%-point increase in THRH was associated with a 0.13%-point increase in TBR (<3.0 mmol/L) (95% confidence interval [CI] = 0.06-0.21), 0.66%-point increase in TBR (3.0-3.9 mmol/L) (95% CI = 0.47-0.86), and 0.74%-point increase in TBR (<3.9 mmol/L) (95% CI = 0.51-0.97), all P < .001. A THRH threshold below 50% was linked to a TBR <3.9 mmol/L of less than 4%, as recommended. Similar results were observed during both day and night analyses and for point-of-care monitored patients, also for hypoglycemic events.

CONCLUSIONS: The THRH is strongly associated with hypoglycemia in non-ICU hospitalized patients with type 2 diabetes on basal-bolus insulin. Aiming for THRH below 50% aligns with the recommended TBR target of <3.9 mmol/L below 4%, supporting THRH's role in guiding hypoglycemia prevention strategies.

来源:J Diabetes Sci Technol,查看原文。版权归原作者所有。

参考来源

  1. Olsen MT, Hansen KB, Pedersen-Bjergaard U, et al. Time at High Risk of Hypoglycemia: Validation of a Consensus-Based Continuous Glucose Monitoring-Metric for Hospitalized Patients. J Diabetes Sci Technol. 2025. PMID: 40219621. doi:10.1177/19322968251331600

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。